With 2.39 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.14 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $6.22 whereas the lowest price it dropped to was $5.0. The 52-week range on BDRX shows that it touched its highest point at $92.00 and its lowest point at $5.00 during that stretch. It currently has a 1-year price target of $180.00. Beta for the stock currently stands at 0.98.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BDRX was down-trending over the past week, with a drop of -17.01%, but this was down by -7.76% over a month. Three-month performance dropped to -11.46% while six-month performance fell -56.17%. The stock lost -84.74% in the past year, while it has lost -90.03% so far this year.
Float and Shares Shorts:
On 2025-10-15, short shares totaled 27160.0, which was 438.0 higher than short shares on 1757894400. In addition to Mr. Stephen Anthony Stamp as the firm’s CEO, CFO, Company Secretary & Director, Dr. Daniel Palmer MBA, Ph.D. serves as its Vice President of Technology.
Institutional Ownership:
Through their ownership of 0.06172 of BDRX’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With BDRX analysts setting a high price target of 177.93785 and a low target of 177.93785, the average target price over the next 12 months is 177.93785. Based on these targets, BDRX could surge 2779.25% to reach the target high and rise by 2779.25% to reach the target low. Reaching the average price target will result in a growth of 2779.25% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.00524682 being high and -$0.00524682 being low. For BDRX, this leads to a yearly average estimate of -$0.00524682.
